Stock Comparison

ARWR vs REGN

Arrowhead Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ARWR

Arrowhead Pharmaceuticals Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$11.11B

$66.35B

P/E (TTM)

—

15.5

Forward P/E

111.1

14.1

Price/Sales

17.9

4.5

Price/Book

18.2

2.1

EV/EBITDA

27.9

10.5

Dividend Yield

—

0.58%

Profitability

Net Margin

-48.40%

29.60%

Operating Margin

-191.60%

20.70%

Return on Equity

-42.40%

14.50%

Return on Assets

-7.22%

6.13%

Growth (YoY)

Revenue Growth

-86.40%

19.00%

Earnings Growth

9.80%

-7.20%

Price & Risk

Beta

1.3

0.2

52-Week High

$84.55

$818.90

52-Week Low

$14.30

$516.07

Analyst Target

$89.08

$833.31

Compare ARWR and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.